Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Telehealth Utilization Is Associated with Lower Risk of Discontinuation of Buprenorphine: a Retrospective Cohort Study of US Veterans
J. Priyanka Vakkalanka, Brian C. Lund, Marcia M. Ward, et al.
Journal of General Internal Medicine (2021) Vol. 37, Iss. 7, pp. 1610-1618
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Telehealth-Based Delivery of Medication-Assisted Treatment for Opioid Use Disorder: a Critical Review of Recent Developments
Hossam Mahmoud, Hady Naal, Emile Whaibeh, et al.
Current Psychiatry Reports (2022) Vol. 24, Iss. 9, pp. 375-386
Open Access | Times Cited: 38
The Use of Digital Health Services Among Patients and Citizens Living at Home: Scoping Review
Milla Rosenlund, Ulla‐Mari Kinnunen, Kaija Saranto
Journal of Medical Internet Research (2023) Vol. 25, pp. e44711-e44711
Open Access | Times Cited: 35
Telemedicine Buprenorphine Initiation and Retention in Opioid Use Disorder Treatment for Medicaid Enrollees
Lindsey R. Hammerslag, Aimee Mack, Redonna K. Chandler, et al.
JAMA Network Open (2023) Vol. 6, Iss. 10, pp. e2336914-e2336914
Open Access | Times Cited: 30
Impact of Telehealth, In-Person, and Hybrid Care Modalities on Buprenorphine Discontinuation Among Patients with Opioid Use Disorder: A Retrospective Cohort Study on Commercially Insured Individuals
Jabed Al Faysal, Md. Noor-E-Alam, Gary J. Young, et al.
(2025)
Closed Access | Times Cited: 1
Duration of medication treatment for opioid‐use disorder and risk of overdose among Medicaid enrollees in 11 states: a retrospective cohort study
Marguerite Burns, Lu Tang, Chung‐Chou H. Chang, et al.
Addiction (2022) Vol. 117, Iss. 12, pp. 3079-3088
Open Access | Times Cited: 38
Management of opioid use disorder and associated conditions among hospitalized adults: A Consensus Statement from the Society of Hospital Medicine
Susan L. Calcaterra, Marlene Martín, Richard Bottner, et al.
Journal of Hospital Medicine (2022) Vol. 17, Iss. 9, pp. 744-756
Open Access | Times Cited: 30
Telehealth Use and Health Equity for Mental Health and Substance Use Disorder During the COVID-19 Pandemic: A Systematic Review
J. Priyanka Vakkalanka, Khyathi Gadag, Lauren Lavin, et al.
Telemedicine Journal and e-Health (2024) Vol. 30, Iss. 5, pp. 1205-1220
Closed Access | Times Cited: 7
Practical Technology for Expanding and Improving Substance Use Disorder Treatment
Mary M. Sweeney, August F. Holtyn, Maxine L. Stitzer, et al.
Psychiatric Clinics of North America (2022) Vol. 45, Iss. 3, pp. 515-528
Open Access | Times Cited: 27
Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population‐based propensity‐score matched cohort study
Tara Gomes, Daniel McCormack, Nikki Bozinoff, et al.
Addiction (2022) Vol. 117, Iss. 7, pp. 1972-1981
Open Access | Times Cited: 19
Patients' Perspectives on Discontinuing Buprenorphine for the Treatment of Opioid Use Disorder
Jessica J. Wyse, Alison Eckhardt, Dylan Waller, et al.
Journal of Addiction Medicine (2024) Vol. 18, Iss. 3, pp. 300-305
Closed Access | Times Cited: 4
Overcoming barriers to traditional care delivery and pharmacy challenges: a qualitative study of buprenorphine, telehealth, and a digital therapeutic for opioid use disorder
Laura B. Monico, Megan Eastlick, Darcy Michero, et al.
Substance Abuse Treatment Prevention and Policy (2025) Vol. 20, Iss. 1
Open Access
The impact of increased telehealth use on the treatment of substance use disorder during the COVID-19 pandemic
Fares Qeadan, Satoko Shimizu, Benjamin Tingey, et al.
SSM - Population Health (2025) Vol. 30, pp. 101780-101780
Open Access
Buprenorphine discontinuation and utilization of psychosocial services: a national study in the Veterans Health Administration
Emma N. Cleary, Angela L. Rollins, Alan B. McGuire, et al.
Addiction Science & Clinical Practice (2025) Vol. 20, Iss. 1
Open Access
Long-Term Prospects for Telemedicine in Opioid Use Disorder (OUD) Treatment: Results from a Longitudinal Survey of OUD Clinicians
Haiden A. Huskamp, Lauren Riedel, Isabella Campa, et al.
Journal of General Internal Medicine (2023) Vol. 38, Iss. 9, pp. 2139-2146
Open Access | Times Cited: 10
An Explainable Machine Learning Framework for Predicting the Risk of Buprenorphine Treatment Discontinuation for Opioid Use Disorder among Commercially Insured Individuals
Jabed Al Faysal, Md. Noor‐E‐Alam, Gary J. Young, et al.
Computers in Biology and Medicine (2024) Vol. 177, pp. 108493-108493
Closed Access | Times Cited: 3
Inequities in the treatment of opioid use disorder: A scoping review
Trevor Magee, Caleb Peters, Samuel M. Jacobsen, et al.
Journal of Substance Use and Addiction Treatment (2023) Vol. 152, pp. 209082-209082
Closed Access | Times Cited: 8
Cost-effectiveness of Increasing Buprenorphine Treatment Initiation, Duration, and Capacity Among Individuals Who Use Opioids
Anneke L. Claypool, Catherine DiGennaro, W. Alton Russell, et al.
JAMA Health Forum (2023) Vol. 4, Iss. 5, pp. e231080-e231080
Open Access | Times Cited: 7
A qualitative study to determine perspectives of clinicians providing telehealth opioid use disorder treatment
Barbara Burke, Emily N. Miller, Brian Clear, et al.
Drug and Alcohol Dependence (2024) Vol. 256, pp. 111118-111118
Closed Access | Times Cited: 2
Traumatic Brain Injury and Opioids: Twin Plagues of the Twenty-First Century
Maya Jammoul, Dareen Jammoul, Kevin Wang, et al.
Biological Psychiatry (2023) Vol. 95, Iss. 1, pp. 6-14
Closed Access | Times Cited: 4
Estimated effectiveness and cost-effectiveness of opioid use disorder treatment under proposed U.S. regulatory relaxations: A model-based analysis
Gary Qian, Keith Humphreys, Jeremy D. Goldhaber‐Fiebert, et al.
Drug and Alcohol Dependence (2024) Vol. 256, pp. 111112-111112
Closed Access | Times Cited: 1
Prescribing Characteristics Associated With Opioid Overdose Following Buprenorphine Taper
Nikki Bozinoff, Siyu Men, Paul Kurdyak, et al.
JAMA Network Open (2022) Vol. 5, Iss. 9, pp. e2234168-e2234168
Open Access | Times Cited: 6
Service users’ perception and attitude toward telemedicine-based treatment for substance use disorders: A qualitative study from India
Abhishek Ghosh, Tathagata Mahintamani, P. V. Aswathy, et al.
Indian Journal of Psychiatry (2023) Vol. 65, Iss. 7, pp. 774-784
Open Access | Times Cited: 3
Risk of Adverse Outcomes Among Veterans Who Screen Positive for Traumatic Brain Injury in the Veterans Health Administration But Do Not Complete a Comprehensive Evaluation: A LIMBIC-CENC Study
Terri K. Pogoda, Rachel Sayko Adams, Kathleen F. Carlson, et al.
Journal of Head Trauma Rehabilitation (2023) Vol. 39, Iss. 3, pp. 171-182
Closed Access | Times Cited: 2
Primary Care Providers’ Experiences Treating Opioid Use Disorder Using Telehealth in the Height of the COVID-19 Pandemic
S. Alexandra Marshall, Lachan E. Siebenmorgen, Katherine Youngen, et al.
Journal of Primary Care & Community Health (2024) Vol. 15
Open Access
Patient perceptions of and experiences with stigma using telehealth for opioid use disorder treatment: a qualitative analysis
Jessica V. Couch, Mackenzie Whitcomb, Bradley M. Buchheit, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top